EP1071459A4 - Methods to provoke anti-cancer immune responses - Google Patents
Methods to provoke anti-cancer immune responsesInfo
- Publication number
- EP1071459A4 EP1071459A4 EP99912724A EP99912724A EP1071459A4 EP 1071459 A4 EP1071459 A4 EP 1071459A4 EP 99912724 A EP99912724 A EP 99912724A EP 99912724 A EP99912724 A EP 99912724A EP 1071459 A4 EP1071459 A4 EP 1071459A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- methods
- immune responses
- cancer immune
- provoke
- provoke anti
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000001093 anti-cancer Effects 0.000 title 1
- 230000028993 immune response Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/45—Transferases (2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001176—Heat shock proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6043—Heat shock proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/605—MHC molecules or ligands thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Peptides Or Proteins (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7893198P | 1998-03-20 | 1998-03-20 | |
US78931P | 1998-03-20 | ||
PCT/US1999/006048 WO1999047169A1 (en) | 1998-03-20 | 1999-03-19 | Methods to provoke anti-cancer immune responses |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1071459A1 EP1071459A1 (en) | 2001-01-31 |
EP1071459A4 true EP1071459A4 (en) | 2002-07-17 |
Family
ID=22147094
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP99912724A Withdrawn EP1071459A4 (en) | 1998-03-20 | 1999-03-19 | Methods to provoke anti-cancer immune responses |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1071459A4 (en) |
JP (1) | JP2002506832A (en) |
AU (1) | AU755706B2 (en) |
CA (1) | CA2322969A1 (en) |
WO (1) | WO1999047169A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6649158B1 (en) | 1998-10-15 | 2003-11-18 | Canji, Inc. | Methods and compositions to induce antitumor response |
AU6497799A (en) * | 1998-10-15 | 2000-05-01 | Canji, Inc. | Methods and compositions to induce antitumor response |
US20020006397A1 (en) * | 2000-04-28 | 2002-01-17 | Roberts Bruce L. | In VIVO loading of MHC |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5242813A (en) * | 1990-10-12 | 1993-09-07 | The United States Of America As Represented By The Department Of Health And Human Services | Mouse monoclonal antibodies specific for normal primate tissue, malignant human cultural cell lines human tumors |
US5314813A (en) * | 1992-02-19 | 1994-05-24 | Scripps Research Institute | Drosophila cell lines expressing genes encoding MHC class I antigens and B2-microglobulin and capable of assembling empty complexes and methods of making said cell lines |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5861156A (en) * | 1993-01-08 | 1999-01-19 | Creative Biomolecules | Methods of delivering agents to target cells |
US6080383A (en) * | 1997-01-13 | 2000-06-27 | Rose; Samuel | Method and composition for the treatment of cancer by the enzymatic conversion of soluble radioactive toxic agents into radioactive toxic precipitates in the cancer |
-
1999
- 1999-03-19 AU AU31036/99A patent/AU755706B2/en not_active Ceased
- 1999-03-19 JP JP2000536408A patent/JP2002506832A/en not_active Withdrawn
- 1999-03-19 CA CA002322969A patent/CA2322969A1/en not_active Abandoned
- 1999-03-19 WO PCT/US1999/006048 patent/WO1999047169A1/en active IP Right Grant
- 1999-03-19 EP EP99912724A patent/EP1071459A4/en not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5242813A (en) * | 1990-10-12 | 1993-09-07 | The United States Of America As Represented By The Department Of Health And Human Services | Mouse monoclonal antibodies specific for normal primate tissue, malignant human cultural cell lines human tumors |
US5314813A (en) * | 1992-02-19 | 1994-05-24 | Scripps Research Institute | Drosophila cell lines expressing genes encoding MHC class I antigens and B2-microglobulin and capable of assembling empty complexes and methods of making said cell lines |
Non-Patent Citations (11)
Title |
---|
BUEELER H ET AL: "INDUCTION OF ANTIGEN-SPECIFIC TUMOR IMMUNITY BY GENETIC AND CELLULAR VACCINES AGAINST MAGE: ENHANCED TUMOR PROTECTION BY COEXPRESSION OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AND B7-1", MOLECULAR MEDICINE, BLACKWELL SCIENCE, CAMBRIDGE, MA, US, vol. 2, no. 5, 1 September 1996 (1996-09-01), pages 545 - 555, XP002035094, ISSN: 1076-1551 * |
CHEN S-H ET AL: "COMBINATION GENE THERAPY FOR LIVER METASTASIS OF COLON CARCINOMA INVIVO", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 92, no. 7, 1995, pages 2577 - 2581, XP000604926, ISSN: 0027-8424 * |
DOWELL R I ET AL: "NEW MUSTARD PRODRUGS FOR ANTIBODY-DIRECTED ENZYME PRODRUG THERAPY: ALTERNATIVES TO THE AMIDE LINK", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. WASHINGTON, US, vol. 39, no. 5, 1996, pages 1100 - 1105, XP002027294, ISSN: 0022-2623 * |
IWADATE YASUO ET AL: "Induction of acquired immunity in rats that have eliminated intracranial gliosarcoma cells by the expression of herpes simplex virus-thymidine kinase gene ganciclovir administration.", ONCOLOGY (BASEL), vol. 54, no. 4, 1997, pages 329 - 334, XP001070213, ISSN: 0030-2414 * |
LINDAUER M ET AL: "GENE TRANSFER OF COSTIMULATORY MOLECULES INTO A HUMANCOLORECTAL CANCER CELL LINE: REQUIREMENT OF CD54, CD80 AND CLASS II MHC EXPRESSION FOR ENHANCED IMMUNOGENICITY", IMMUNOLOGY, BLACKWELL SCIENTIFIC PUBLICATIONS, GB, vol. 93, no. 3, March 1998 (1998-03-01), pages 390 - 397, XP000876810, ISSN: 0019-2805 * |
NICULESCU-DUVAZ I ET AL: "GENE-DIRECTED ENZYME PRODRUG THERAPY", BIOCONJUGATE CHEMISTRY, AMERICAN CHEMICAL SOCIETY, WASHINGTON, US, vol. 9, no. 1, 1 March 1998 (1998-03-01), pages 4 - 22, XP000729231, ISSN: 1043-1802 * |
OSTRAND-ROSENBERG S ET AL: "TUMOR-SPECIFIC IMMUNITY CAN BE ENHANCED BY TRANSFECTION OF TUMOR CELLS WITH SYNGENEIC MHC-CLASS-II GENES OR ALLOGENEIC MHC-CLASS-I GENES", INTERNATIONAL JOURNAL OF CANCER, NEW YORK, NY, US, no. SUPPL 6, 1991, pages 61 - 68, XP002065931, ISSN: 0020-7136 * |
See also references of WO9947169A1 * |
VILE R G ET AL: "SYSTEMIC GENE THERAPY OF MURINE MELANOMA USING TISSUE SPECIFIC EXPRESSION OF THE HSVTK GENE INVOLVES AND IMMUNE COMPONENT", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, BALTIMORE, MD, US, vol. 54, no. 23, 1 December 1994 (1994-12-01), pages 6228 - 6234, XP001061699, ISSN: 0008-5472 * |
YAMAMOTO SHIRO ET AL: "Herpes simplex virus thymidine kinase/ganciclovir-mediated killing of tumor cells induces tumor-specific cytotoxic T cells in mice.", CANCER GENE THERAPY, vol. 4, no. 2, 1997, pages 91 - 96, XP001069247, ISSN: 0929-1903 * |
YEE C ET AL: "Prospects for adoptive T cell therapy", CURRENT OPINION IN IMMUNOLOGY, CURRENT BIOLOGY LTD, XX, vol. 9, no. 5, October 1997 (1997-10-01), pages 702 - 708, XP004313589, ISSN: 0952-7915 * |
Also Published As
Publication number | Publication date |
---|---|
JP2002506832A (en) | 2002-03-05 |
WO1999047169A1 (en) | 1999-09-23 |
AU3103699A (en) | 1999-10-11 |
AU755706B2 (en) | 2002-12-19 |
EP1071459A1 (en) | 2001-01-31 |
CA2322969A1 (en) | 1999-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0103085A3 (en) | Formulations an processes for inducing an immune response to polysaccharide | |
HK1061403A1 (en) | ANTIBODIES TO HUMAN IL-1ß | |
AU2002225512A1 (en) | Immune system stimulation | |
EP0999847A4 (en) | Health supplement | |
HUP0104031A3 (en) | Novel process to prepare microencapsulated formulations | |
GB0100777D0 (en) | Device related to risers | |
AU1702102A (en) | Device for connecting to each other three flat elements | |
HUP0201222A3 (en) | Use of soluble constimulatory molecules to enhance immune responses | |
HU9902702D0 (en) | Device to stop lift | |
EP1071459A4 (en) | Methods to provoke anti-cancer immune responses | |
PL319735A1 (en) | Natural antioxidative preparation | |
AU2002239441A1 (en) | Methods and compositions for inducing cell-mediated immune responses | |
GB9716924D0 (en) | Improvements relating to nerve testing devices | |
IL157614A0 (en) | Uses of opg ligand to modulate immune responses | |
AU6604701A (en) | Method to induce the TH1 immune response | |
EP1114059A4 (en) | Regulation of immune responses by attractin | |
GB2351905B (en) | Eliciting improved immune responses | |
GB9807062D0 (en) | Immune response | |
GB9822619D0 (en) | Immune response stimulation | |
IL126464A (en) | Water-binding composition for foods | |
GB2333938B (en) | Improvements to cultivator | |
GB9930294D0 (en) | Improvements in or relating to immune responses to HIV | |
GB0025234D0 (en) | Improvements in or relating to immune responses to HIV | |
GB9727410D0 (en) | Improvements relating to adjustable furniture | |
GB9727230D0 (en) | Improvements relating to adjustable furniture |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20000920 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20020604 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
17Q | First examination report despatched |
Effective date: 20020902 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
18W | Application withdrawn |
Effective date: 20021219 |